INTRODUCTION
The probiotic bacterium Escherichia coli Nissle 1917 (EcN, Mutaflor) has been applied for many years in the therapy of gastrointestinal disorders. Clinical studies confirmed its beneficial effects in patients with inflammatory bowel disease, for example, to prevent relapse in ulcerative colitis.
1,2 Consequently, this microorganism was subject to intense research in the past decades and different beneficial properties were reported. Although EcN is not capable of penetrating into mucosal cells by itself, it was found to inhibit invasion of pathogenic enteroinvasive microorganisms 3 that are often causative agents of diarrhea and inflammation. In addition, EcN comprises immune modulatory properties, for example, it induced expression of the antimicrobial peptide b-defensin-2 in human colonic epithelial cells. 4 This was mediated by flagellin that is present in EcN culture supernatant. 5 Moreover, a second bacterial factor TcpC was reported to play a role for protecting mice from dextran sodium sulfate-induced colitis (Julia Frick, University Tübingen, personal communication). Furthermore, EcN was suggested to directly stabilize the intestinal barrier, a main structural feature of innate immunity in the gut, by regulating barrier-associated proteins in epithelial cells. Accordingly, it was described that EcN stimulated the expression of zonula occludens protein-2 (ZO-2) and desmosome protein pinin in T84 cells. 6, 7 Also, expression of zonula occludens protein-1 (ZO-1) was reported to be enhanced by EcN administration to germfree mice as well as in a mouse model of colitis. 8 Epithelial tight junctions (TJs) localized in the apical contact zone of adjacent enterocytes play a key role in regulating intestinal barrier properties. 9, 10 ZO proteins (ZO-1, -2, and -3) are membrane-associated cytosolic proteins functioning as scaffold proteins in the organization of TJ strands [11] [12] [13] by forming an anchor for different types of transmembranal proteins, such as occludin, 14 claudins, 15 and tricellulin. paracellular diffusion. In recent years, several claudins were linked either with a sealing function or a specific channel function. Hence, the tissue-specific structural and physiological function of the TJs depends on the composition of these TJ proteins and their interaction with each other as well as with scaffold proteins, cytoskeleton-associated proteins, and regulatory components. 17 The integrity of the TJs can be influenced by different intra-or extracellular stimuli. In cell culture studies this was mediated by associated protein kinases, such as the mitogen-activated protein kinases, 18 protein kinase C (PKC), 19 or phosphatidylinositol-3-kinase. 20 Several studies suggested probiotic microorganisms as regulators of TJs and thus of the intestinal epithelial barrier. Recently, a factor secreted by Bifidobacterium infantis was shown to enhance occludin and ZO-1 protein level and to decrease the expression of the channel-former claudin-2 in T84 cells. 21 In mice, the probiotic mixture VSL3 prevented colitis-associated changes in occludin, ZO-1, and claudin-1, -3, -4, and -5. 22 However, so far, the impact of EcN on proteins that directly determine properties of the paracellular epithelial barrier-the sealing or channel-forming TJ proteins-has not been described. Therefore, this study addressed the mechanisms of EcN-mediated increase of paracellular barrier function with special attention to claudins and tricellulin. In contrast to other studies, 3, 8 we investigated unchallenged epithelial cells treated with a highly active EcN culture supernatant.
RESULTS

EcN increases transepithelial resistance (TER) in different intestinal epithelial models
Treatment of HT-29/B6 monolayers with vital E. coli strains for 24 h showed different effects on TER (Figure 1a) . Common laboratory strains, such as DH5a, ATCC11229, or VSC257, had no effect on TER or even reduced it slightly. Enteropathogenic E. coli, a typical causative agent of diarrhea, decreased TER. In contrast, probiotic EcN induced an increase in TER. Interestingly, Lactobacillus casei Shirota, another probiotic strain, had no effect on TER (Figure 1a) . Comparable TER effects of EcN were also observed in Caco-2 monolayers (Figure 1b) . Moreover, two-path impedance measurements performed on colonic specimens obtained from piglets, which underwent supplement feeding with EcN, revealed an increase in paracellular resistance compared with untreated controls (Figure 1c) .
As it is known that EcN secrets active factors into the culture medium, 4,5 the impact of EcN culture supernatant (EcN sup ) on TER was examined. Treatment with EcN sup also increased TER over time (Figure 2a) , whereas L. casei Shirota culture supernatant was ineffective (data not shown). The effect of EcN sup on TER could be abolished by intensive heat treatment (EcN sup 951C, Figure 2a ) and was also diminished by proteinase K digestion, suggesting a proteinaceous component (Figure 2a) . Subsequently, supernatants of two EcN mutant strains were studied regarding their potential to stimulate TER. Although the supernatant of the DfliA mutant strain (DfliA sup ), which is incapable of flagella gene transcription, increased TER comparable to the wild-type strain, supernatant of the tcpCdeficient strain (DtcpC sup ) had lost this ability and TER remained at control level within 24 h of incubation ( Figure 2b) . To assess the beneficial TcpC effect, tcpC from EcN was cloned into the tcpC-negative laboratory E. coli strain TOP10F. TOP10F carrying tcpC from EcN (clone 5) increased TER in HT-29/ B6 monolayers compared with wild-type TOP10F treated or untreated control monolayers (Figure 2c ).
Effect of EcN on intracellular signaling pathways
EcN was recently described to affect the atypical PKC-z (PKCz). 23 We found that EcN sup increased PKCz phosphorylation within 10-20 min and that phosphorylation of extracellular signal-regulated kinases 1/2 (ERK1/2) was induced at 30 min (Figure 3a) . Interestingly, the DtcpC mutant strain did not stimulate PKCz or ERK1/2 phosphorylation (Figure 3b ,c, quantification is given in Supplementary Figure S1 online). Involvement of other mitogen-activated protein kinases (p38 or c-Jun N-terminal kinase) or phosphatidylinositol-3-kinase, which are often functionally linked to PKC signaling, was not observed (data not shown).
Improvement of paracellular barrier function
The following analyses were performed on HT-29/B6 monolayers after 24 h of incubation with EcN sup . If not stated otherwise, untreated monolayers served as control. To study electrophysiological properties, monolayers were mounted into Ussing chambers, and TER and short circuit currents (I SC ) were determined and unidirectional flux measurements were performed from mucosal to serosal with [ 3 H]-mannitol (182 Da, radius 3.6 Å). As shown in Table 1 , I SC was not affected by EcN sup , which points against a change in a rheogenic transport process contributing to the resistance effect. In support of this hypothesis, the increase in TER was accompanied by a reduction in mannitol permeability. Two-path impedance spectroscopy was performed to differentiate between trans-and paracellular resistance. EcN sup improved the barrier function predominantly by sealing the paracellular route (Figure 4a) . In EcN sup -treated monolayers, paracellular resistance (R para ) was 3.4-fold higher than in controls and this was the main contribution to the increase in transepithelial electrical resistance (R epi ). In contrast, transcellular resistance (R trans ) contributed only marginally. Because this paracellular effect pointed towards TJ changes, expression of several barrier-relevant TJ proteins was studied. In western blot analyses performed after 24 h of EcN The time course is given in Figure 7a and shows that TER in claudin-14 siRNA-transfected cell layers amounted to only 53±3% of that in monolayers transfected with green fluorescent protein (GFP) siRNA as control. In parallel, protein expression of claudin-14 was reduced in claudin-14 siRNA-transfected cells compared with monolayers transfected with GFP siRNA (69 ± 9% in claudin-14 siRNA compared with control, Figure 7b ,c).
DISCUSSION
Deterioration of the intestinal barrier has two major consequences: (i) electrolytes and water can leak into the intestinal lumen contributing to diarrhea (leak flux diarrhea) and (ii) increased transmucosal permeation of noxious and/or immunogenic agents may occur. The ''sealing'' action of EcN likely improves intestinal barrier function and thus may-at least in part-explain the observed benefits in patients. So far, EcN-induced barrier improvement was attributed to upregulation of ZO proteins. 6, 8, 23 However, barrier function is directly dependent on the presence and composition of transmembranal TJ proteins such as the claudins, whereas ZO proteins rather provide scaffold and regulate their interplay. 25 Consequently, Transepithelial resistance (TER) was measured (n ¼ 6-9, **Po0.01) and (b) permeabilities to sodium (P Na ) and chloride (P Cl ) were determined by measurement of dilution potentials (n ¼ 6 or 9; P Na : ***Po0.001; P Cl : ### Po0.001 vs. control). (c) The permeability ratios P Na /P Cl in EcN sup -treated monolayers was not different from that of nonstimulated controls.
this study was conducted to examine EcN influence on strandforming TJ proteins and to elucidate the TJ-modulating bacterial factor. In contrast to laboratory E. coli strains, enteropathogenic E. coli, or the probiotic strain L. casei Shirota, treatment of HT-29/B6 monolayers with vital EcN or EcN sup resulted in strongly increased TER. This effect was not unique to HT-29/B6 cells as it was confirmed in Caco-2 monolayers. Moreover, we observed effects on R para in piglet colon specimens supporting the barrier-stabilizing properties of EcN that were already assumed from clinical studies.
1,2 TER effects on unchallenged epithelial cells were already reported for other vital probiotic preparations, for example, Streptococcus thermophilus or Lactobacillus acidophilus. 26 Soluble as well as structurally bound signaling molecules are typical for communication/interaction of the gut microbiota with the host. With respect to EcN, different structures such as flagellin or the capsule polysaccharide are well known to exhibit immune stimulatory properties. 5, 27, 28 However, flagellin was not responsible for the EcN-mediated effect demonstrated in this study, because a flagella-defective strain was still effective. However, the TER effect turned out to be mediated by the TcpC protein, as DtcpC sup did not stimulate TER anymore. As a further piece of evidence, cloning of EcN tcpC into E. coli TOP10F caused this strain to develop a TER increase in HT-29/B6 monolayers too. These findings are in line with data from a mouse dextran sulfate sodium colitis model where EcN TcpC proved to be an important protective bacterial factor (Julia Frick, Tübingen, personal communication). Originally, TcpC, which refers to TIR domain containingprotein, was characterized in an uropathogenic E. coli strain CFT073. Here, TcpC was secreted and reported to impede TLR signaling through direct binding to the adaptor protein MyD88 with its TIR domain. 29 From this work, TcpC was established as a virulence factor for urinary tract infection. So far, the role of TcpC in EcN is not known. As TLR agonists do not lead to an increase in TER in our model, it may well be that the protective effect on epithelial cells seen in our model is mediated by a different mechanism. In this study we found that TcpC regulates the phosphorylation of PKCz and ERK1/2 in an epithelial cell line. Using T84 cells, Zyrek et al. 23 already reported an influence of EcN on PKCz. In this study, EcN enhanced the expression and translocation of PKCz from the cytosol to the membrane, but reduced its activity. PKCz belongs to the atypical protein kinases and acts as a serine/threonine protein kinase. It forms a complex with the cell polarity proteins PAR-6 and PAR-3 that control TJ formation as, for example, shown in MDCK (Madin Darby canine kidney) cells. 30 Recently, induction of PAR-3 and PAR-6 mRNA by EcN was reported in T84 cells. 7 However, the functional relevance and the bacterial factor of this finding were not clear yet. Activation of PKCz involves the release of a pseudosubstrate and a phosphorylation in the kinase domain and is influenced by phosphatidylinositol-3,4,5-trisphosphate, which is produced from phosphatidylinositol-4,5-bisphosphate by phosphatidylinositol-3-kinase. In our study, we did not observe any involvement of phosphatidylinositol-3-kinase (data not shown), but EcN sup incubation enhanced the phosphorylation of ERK1/2.
Subsequent analyses of the EcN-induced barrier effect pointed to a TJ contribution. EcN sup reduced mannitol permeability that, because of its size, can pass the paracellular barrier. 31 In addition, two-path impedance analysis revealed that the EcN-mediated TER increase is mainly because of increased paracellular resistance. For identifying the nature of this paracellular effect, expression and localization of most of the functionally important TJ strand proteins was studied by 7, 23 EcN could also enhance the assembly of TJs by preferentially stimulating the insertion of claudin-14 into TJ strands.
Although western blot did not show any changes in occludin protein expression, immunofluorescence staining appeared to indicate enhanced signals in TJs. The functional relevance of this observation is not clear. From knockout mice it is known that occludin is not obligate for intact barrier function and it was speculated to be dispensable when substituted by other TJ proteins. 32 In contrast to other studies performed on diverse cell and animal models, 6, 8, 23 we did not see EcN sup to stimulate ZO-1 expression in HT-29/B6. This may simply depend on the model, as it is not unlikely that EcN acts differently under pathological or germ-free conditions or redundancy of ZO proteins is different in our cell model. Enhanced expression of ZO proteins may stabilize the TJs and improve the morphology of damaged epithelia. However, in contrast to strand-forming TJ proteins, ZO scaffold proteins have no direct influence on TER.
Interestingly, we found EcN-induced claudin-14 upregulation to involve PKCz and ERK1/2 signaling. As neither inhibition of PKCz nor of ERK1/2 alone abolished the EcN sup effect, simultaneous PKCz and ERK1/2 inhibition was tested. TER was slightly decreased by the inhibitor combination, indicating that these pathways are relevant for barrier function. Under these conditions, EcN sup was no longer able to induce a significant TER increase. In fact, regulation of claudin-14 depended on the interplay of both signaling components, e.g. because of parallel signaling pathways toward claudin-14 within the TJ. PKCz is involved in the mitogen-activated protein kinase cascade in a variety of cells. [33] [34] [35] In a recent study the influence of ERK1/2 on TJ integrity was dependent on cell differentiation status. Although ERK1/2 destabilizes the TJs in immature Caco-2 cell layers, it mediates protection and stabilization of the TJs in fully differentiated cells. In the latter case, epidermal growth factor stimulated PKCz and enhanced its localization at the TJs, which was ERK dependent. 36 Moreover, the ability to stimulate PKC/ERK1/ 2 signaling seems not to be restricted to EcN. For example, secretory proteins of probiotic Lactobacillus rhamnosus GG were observed to protect intestinal epithelial TJs from hydrogen peroxide damage in a PKC-and mitogen-activated protein kinase-dependent manner. 37 Although deletion of claudin-14 is known to be associated with deafness, 38, 39 its function in the intestine is unknown. Expression of claudin-14 in a leaky canine kidney cell line (MDCK-II) resulted in a TER increase, pointing to sealing properties. 24 This is in accordance with the results obtained from our siRNA transfection approach in this study. Here diminished claudin-14 protein expression was accompanied by TER reduction. However, selective discrimination against sodium as described for claudin-14 overexpression in MDCK-II 24 EcN exerts a multimodal effect on the epithelial gut barrier. Beside other mechanisms, its probiotic properties comprise an epithelial barrier strengthening function. From this study we obtained experimental evidence that supernatant from E. coli Nissle lacking tcpC (i) has lost its ability to enhance TER, (ii) was unable to stimulate phosphorylation of PKCz and ERK1/2, and (iii) accordingly did not induce claudin-14 upregulation. Thus, we conclude that the increase in TER on HT-29/B6 monolayers is mediated by the TcpC protein of EcN through PKCz and ERK1/2 signaling. Claudin-14 has barrier-forming properties and contributes to EcN-induced barrier improvement.
METHODS
Cell culture. The colon carcinoma cell line HT-29/B6, a subclone of the human colon carcinoma cell line HT-29, is an appropriate model to study TER, reflecting barrier integrity. 41 Culture medium contained RPMI-1640 (PAA Laboratories GmbH, Pasching, Austria) for HT-29/ B6 or MEM þ GlutaMax (Life Technologies GmbH, Darmstadt, Germany) for Caco-2, 15% fetal calf serum, and 1% penicillin/ streptomycin. Cells were incubated at 37 1C in an air atmosphere containing 5% CO 2 . For experimental analyses, cells were seeded on Millicell PCF filter supports (effective area: 0.6 cm 2 ; 3 mm pores Millicell PCF, Millipore, Schwalbach, Germany) and experiments were performed when confluent monolayers were fully polarized.
Construction of EcN DTcpC gene knockout. To selectively remove the TcpC gene from the chromosome of EcN strain, the single step gene knockout procedure was performed, as described by Datsenko and Wanner. 42 In brief, oligonucleotide primers were designed for introducing a kanamycin resistance gene cassette, so that the open reading frame of the TcpC gene was selectively replaced by a kanamycin resistance gene. Primers used were: (i) P1.Tir.for: 5 0 -TAGTAATGTTATCCCCACTATTAATTTTTAATCAAATGCATG TTACATAGGCTCAGTGTAGGCTGGAGCTGCTTC-3 0 and (ii) P2.Tir.rev: 5 0 -CACGGAACACTCATTCCATAACAAACATACTAT TTAGATGTGCTAATACAATTAATCATATGAATATCCTCCTTA-3 0 . Annealing regions of 20 bp homologous to the kanamycin resistance cassette template plasmid, pKD4, were included as well as 55 bp of sequence homologous to regions flanking the EcN TcpC gene. The purified PCR product obtained was subsequently electroporated into EcN, which had previously been transformed with the lambda Red recombinase expression vector, pKD46 bearing a heat-labile origin. To facilitate recombination of the electroporated fragment, expression of lambda Red recombinase in EcN cells was induced by treatment with 100 mM arabinose at 27 1C. After the transformation of the PCR fragment into EcN (pKD46), cells were recovered in Luria Broth at 37 1C under agitation. Kanamycin-resistant transformants were grown at 37 1C to induce the loss of the heat-labile pKD46 plasmid. Loss of pKD46 plasmid was confirmed by loss of resistance against Ampicillin. Final knockout isolates were screened by PCR for the absence of the TcpC gene and the presence of the kanamycin cassette. Further confirmation was performed by sequencing of the upstream and downstream insertion sites.
Construction of E. coli TOP10F EcN TcpC strain. To artificially introduce a functional copy of TcpC derived from the original strain EcN into K-12 strain Top10F, the respective region from the chromosome of EcN was amplified using the oligonucleotide primers SerU-Island.10670.for 5 0 -GCAACGCATATGATAGTAAT-3 0 and tcp C.LongRekomp.rev 5 0 -CAATATGTGGAATGAGCA-3 0 . The amplified 3.5-kb fragment was cloned into the PCR4 TOPO vector by means of TA cloning (Life Technologies GmbH) according to the manufacturer's instructions. Confirmatory sequencing was performed. The plasmid was subsequently isolated and transformed into TOP10F electrocompetent cells.
EcN piglet feeding trial. Piglets (28 days of age) were fed a standard chow and water ad libitum supplemented either with or without EcN every second day (1 Â 10 9 CFU given by oral gavage, controls received saline). After 2 weeks, the colon was removed and specimens were partially stripped and inserted into Ussing-type chambers. One-and two-path impedance spectroscopy were performed as described below.
Preparation of EcN supernatant. EcN was grown in 4 ml LuriaBertani Broth (MP Biomedicals, Illkirch, France) overnight at 37 1C. The next day, 20 ml Luria-Bertani Broth was inoculated from overnight culture to an optical density (OD5 578 nm ) of 0.4. Bacteria were cultured to an OD 578 of at least 1 and were used for preparation of a further culture, starting with an OD 578 of 0.3. When an OD 578 above 1 was reached, Luria-Bertani Broth was removed by centrifugation at 5,000 Â g and the pellet was washed with RPMI-1640 medium without phenol red (PAA Laboratories GmbH). The bacterial pellet was resuspended to an OD 578 of 2. From this a preparative culture was inoculated to an OD 578 of 0.3 and EcN was grown in RPMI to an OD 578 of 1.5. This preparative culture was centrifugated at 8,000 Â g for 15 min at 4 1C. The supernatant was filtrated using Sterivex-GV 0.22 mm (Millipore) and afterwards concentrated using Centricon Plus-20 centrifugal filters (Millipore) with a molecular weight cutoff MWCO of 100 kDa.
Treatment of HT-29/B6 monolayers with bacteria or supernatant.
For infection procedures with viable bacteria, monolayers were shifted to serum and antibiotic-free RPMI medium 2 h before experiments. All E. coli strains were grown in Luria Bertani Broth, and EcN mutant strains were cultured in the presence of 50 mg ml À 1 kanamycin. L. casei Shirota was raised under anaerobic conditions in de Man, Rogosa, and Sharpe medium (Roth, Karlsruhe, Germany).
A 1:8 dilution of the bacterial overnight culture was incubated for additional 1.5 h at 37 1C. Bacteria were harvested from log-phase cultures, washed, and resuspended in RPMI or MEM þ GlutaMax. Cells were treated with 10 7 or 10 8 vital bacteria from the apical side equaling a multiplicity of infection of 10 or 100. Incubation was carried out at 37 1C in an atmosphere of 95% O 2 and 5% CO 2 for 24 h. To avoid overgrowth, bacteria were killed by the addition of 100 mg ml À 1 gentamicin at 3 h after inoculation. All investigated strains are listed in Table 2 .
Before treatment with supernatant, HT-29/B6 cells were placed into serum-free RPMI medium containing 100 mg ml À 1 gentamicin. Signaling pathways were examined by preincubation of HT-29/B6 monolayers with 1 mM protein kinase C-zeta pseudosubstrate, myristoylated (Life Technologies GmbH) and 10 mM U0126 (Calbiochem, Darmstadt, Germany). EcN sup was added after 4 h of pretreatment. Flux measurement. At 24 h after infection, HT-29/B6 cell monolayers were mounted into Ussing chambers. TER was determined by a computerized automatic clamp device (Fiebig Hard & Software, Berlin, Germany) and unidirectional flux measurement was performed from mucosal to serosal under short circuit conditions with [ 3 H]-mannitol (Biotrend, Cologne, Germany) according to previously described protocols. 45 The bathing solution contained nonlabeled mannitol (10 mM). Then, [ 3 H]-mannitol was added to the mucosal side and samples were taken from the basolateral chamber at 0, 15, 30, 45, and 60 min. Ultima Gold high flash-point liquid scintillation cocktail (PerkinElmer LAS GmbH, Rodgau-Juegesheim, Germany) was used for analysis in a Tri-Carb 2100TR liquid scintillation counter (Packard, Frankfurt, Germany).
Two-path impedance spectroscopy. R epi , R trans , and R para of HT-29/ B6 monolayers were measured by two-path impedance spectroscopy as recently published. 45 Briefly, filters were mounted in Ussing-type impedance chambers and bathed with Ringer's solution. Sinusoidal alternate currents at frequencies from 1 to 65 kHz were provided by an electrochemical interface (1286, Solartron Schlumberger, Farnborough, UK), connected to a phase-sensitive multimeter (PSM 1700 PsimetriQ, Newtons4th, Loughborough, UK). In addition, fluxes of the paracellular marker fluorescein were measured. Change of R para was induced by Ca 2 þ removal using EGTA and the resulting impedance spectra and fluxes before and after chelating extracellular Ca 2 þ were used for calculation.
Confocal laser scanning microscopy. After an incubation period of 24 h, HT-29/B6 monolayers were washed and fixed with methanol for 1 h at À 20 1C followed by an aceton treatment of 5 min. Afterwards, monolayers were rehydrated with immunofluorescence medium (0.1% Triton X-100, 0.15 M NaCl, 5 mM EDTA, 20 mM HEPES, pH 7.5, Western blot. Protein expression was analyzed using the western blot technique as described previously. 46 At 24 h after treatment, whole-cell extracts were generated with ice-cold lysis buffer including 10 mM Tris, pH 7.5, 150 mM NaCl, 0.5% Triton X-100, and 0.1% SDS. For detection of ZO proteins, cells were lysed by ultrasonification using a buffer including 25 mM Hepes, 20 mM EDTA, 25 mM NaF, 1% SDS, and complete protease inhibitor mixture (Roche). To check for phosphorylation, lysis buffer contained 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM Na 2 H 2 P 2 O 7 , 1 mM b-glycerolphosphate, 1 mM Na 3 VO 4 , 1 mg ml À 1 leupeptin, and 1 mM PMSF. Before use, complete protease inhibitor mixture (Roche) was added.
Protein concentrations were determined by Pierce BCA assay (Thermo Scientific, Ulm, Germany) and 15-25 mg of whole cell extracts were loaded on polyacrylamid gels. For immunodetection the following antibodies were used: anti-occludin and anti ZO-1 (1:2,000, Zymed), anti-tricellulin (customized by the group of O. Huber, Institute of Clinical Chemistry and Pathobiochemistry, Charité, Germany.), anti-claudin-1 -5, -7, -8, and -10 (1:1,000, Zymed), anti-claudin-14 (1:1,000, LifeSpan BioSciences, SEA), anti-pPKCz(Thr410)-R (1:200, Santa Cruz Biotechnology, Heidelberg, Germany), anti-PKCz (1:1,000, Cell Signaling Technology, Frankfurt am Main, Germany), p-p44/42 and p44/42 (1:1,000, Cell Signaling Technology), and anti-b-actin (1:5,000, Sigma-Aldrich, Schnelldorf, Germany) as internal loading control.
Measurement of Na
þ and Cl -permeability. At 24 h after incubation, EcN sup -treated monolayers and controls were mounted into Ussing chambers and water-jacketed gas lifts were filled with 10 ml circulating Ringer's solution (in mM: Na þ 140; Cl -149.8; K þ 5.4; Ca 2 þ 1.2; Mg 2 þ ; HEPES 10 and D( þ )-glucose; pH 7.4). The TER effect on pretreated monolayers was stabilized by the addition of 30 ml of EcN sup to the apical compartment. Sab simplex (Pfizer Pharma GmbH, Berlin, Germany) was used to reduce surface tension. To avoid contribution through altered ion channel activity, NaCl dilution potentials were measured at 14 1C. Briefly, voltage and TER (O cm 2 ) were monitored and one hemichamber was switched to a solution containing a reduced concentration of NaCl, whereas all other components were identical to standard Ringer's solution. Osmolarity was balanced by mannitol. NaCl permeability was determined from dilution potentials and the Goldmann-Hodgkin-Katz equation as reported previously. 40, 47, 48 siRNA transfection assay. For transfection of HT-29/B6 cells with claudin-14 siRNA, the Amaxa biosystems siRNA kit (Lonza Cologne AG, Cologne, Germany) was used. A total of 1 Â 10 6 cells were transfected with 10 ml of claudin-14 siRNA (Santa Cruz, Heidelberg, Germany) or 5 ml maxGFP siRNA (Lonza Cologne AG) as vector control according to the manufacture's protocol. After transfection, cells were immediately seeded on Millicell PCF filters and the course of TER was monitored for B3 days.
